483 Malladi Drugs & Pharmaceuticals Oct 2018

483 Malladi Drugs & Pharmaceuticals Oct 2018

Kellia Hicks FDA$119.00 - Available Now

FDA investigators audited the Malladi Drugs & Pharmaceuticals - Gajulamandyam, India facility and issued inspectional observations (via FDA 483) on 09 Oct 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 09 Oct 2018
  • Location: Gajulamandyam, India
  • FEI: 3004896422
Add To Cart